![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ACCELERATION THERAPEUTICS' AT-101 DEVICE PROVIDES BENEFICIAL EFFECT OF VASODILATATION IN PUBLISHED STUDY
ACCELERATION THERAPEUTICS' AT-101 DEVICE PROVIDES BENEFICIAL EFFECT OF VASODILATATION IN PUBLISHED STUDY
Acceleration Therapeutics has announced that a published study using its AT-101 passive exercise device showed, for the first time, that the AT-101 produces an important benefit that also occurs with active exercise.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050118005390&newsLang=en)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct